GSA CAPITAL PARTNERS LLP - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$346,000
+765.0%
672,158
+1145.6%
0.06%
+163.6%
Q2 2020$40,000
-82.8%
53,961
-78.4%
0.02%
-62.1%
Q1 2020$233,000
+348.1%
250,271
+1273.2%
0.06%
+728.6%
Q3 2019$52,000
-94.0%
18,225
-72.1%
0.01%
-92.0%
Q1 2019$869,000
-8.4%
65,415
+7.4%
0.09%
-19.3%
Q4 2018$949,000
-20.7%
60,9000.0%0.11%
+65.2%
Q3 2018$1,197,000
-39.7%
60,900
-27.4%
0.07%
-37.1%
Q1 2018$1,984,000
+266.7%
83,900
+267.0%
0.10%
+183.8%
Q3 2017$541,000
+16.8%
22,862
+3.2%
0.04%
+48.0%
Q3 2016$463,000
-13.0%
22,155
+6.2%
0.02%
-13.8%
Q2 2016$532,000
-59.7%
20,860
-58.2%
0.03%
-65.5%
Q1 2016$1,320,000
+52.2%
49,899
+146.3%
0.08%
+100.0%
Q4 2015$867,000
-46.7%
20,262
-67.0%
0.04%
-47.5%
Q3 2015$1,628,000
+173.2%
61,403
+243.6%
0.08%
+247.8%
Q2 2015$596,000
-48.4%
17,870
-48.5%
0.02%
-50.0%
Q1 2015$1,155,000
-33.7%
34,694
-18.6%
0.05%
-62.3%
Q4 2014$1,742,000
+52.1%
42,614
+26.1%
0.12%
+103.3%
Q3 2014$1,145,000
-6.5%
33,801
-6.9%
0.06%
+9.1%
Q2 2014$1,224,000
+114.4%
36,315
+140.9%
0.06%
+34.1%
Q1 2014$571,000
-37.4%
15,075
-51.8%
0.04%
-43.1%
Q4 2013$912,000
+73.1%
31,247
+103.3%
0.07%
+71.4%
Q3 2013$527,000
+18.7%
15,370
+14.2%
0.04%
-20.8%
Q2 2013$444,00013,4550.05%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders